Norris Medicines Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	72.84	58.2	56.36	83.59	94.38	122.51
Revenue Growth (YoY)	76.48%	3.28%	-32.58%	-11.44%	-22.96%	56.19%
Cost of Revenue	48.52	35.08	26.99	35.23	57.25	89.07
Gross Profit	24.32	23.12	29.36	48.36	37.13	33.44
Selling, General & Admin	16.35	14.13	18.21	22.98	23.38	31
Other Operating Expenses	13	11.2	12.94	16.13	14.39	19.85
Operating Expenses	34.53	30.7	36.86	45.4	44.33	57.53
Operating Income	-10.21	-7.58	-7.5	2.95	-7.2	-24.09
Interest Expense	-4.71	-4.21	-3.66	-14.89	-14.73	-16.2
Interest & Investment Income	0.18	0.18	0.18	0.12	0.12	0.13
Currency Exchange Gain (Loss)	0.01	0.01	0.04	-	0.05	-0.01
Other Non Operating Income (Expenses)	-0.07	-0.19	-0.04	-0.12	-0.09	0.23
EBT Excluding Unusual Items	-14.79	-11.78	-10.98	-11.93	-21.85	-39.93
Pretax Income	-14.79	-11.78	-10.98	-11.93	-21.85	-39.93
Income Tax Expense	0.59	0.59	0.89	5.56	10.79	9.69
Net Income	-15.39	-12.37	-11.87	-17.49	-32.63	-49.62
Net Income to Common	-15.39	-12.37	-11.87	-17.49	-32.63	-49.62
Shares Outstanding (Basic)	10	10	10	10	10	10
Shares Outstanding (Diluted)	10	10	10	10	10	10
EPS (Basic)	-1.54	-1.24	-1.19	-1.75	-3.26	-4.96
EPS (Diluted)	-1.55	-1.24	-1.19	-1.75	-3.26	-4.96
Free Cash Flow	7.11	4.91	1.69	11.7	-10.65	10.26
Free Cash Flow Per Share	0.71	0.49	0.17	1.17	-1.06	1.03
Gross Margin	33.39%	39.72%	52.10%	57.86%	39.34%	27.29%
Operating Margin	-14.02%	-13.03%	-13.31%	3.54%	-7.63%	-19.66%
Profit Margin	-21.13%	-21.26%	-21.06%	-20.93%	-34.58%	-40.50%
Free Cash Flow Margin	9.77%	8.44%	2.99%	13.99%	-11.28%	8.37%
EBITDA	-5.04	-2.21	-1.78	9.25	-0.63	-17.42
EBITDA Margin	-6.91%	-3.80%	-3.17%	11.07%	-0.67%	-14.22%
D&A For EBITDA	5.17	5.37	5.71	6.3	6.57	6.67
EBIT	-10.21	-7.58	-7.5	2.95	-7.2	-24.09
EBIT Margin	-14.02%	-13.03%	-13.31%	3.54%	-7.63%	-19.66%
Revenue as Reported	73.57	58.82	56.64	83.73	94.64	123.04
Advertising Expenses	-	0.06	-	-0.01	0.08	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.